Periodontal condition and total antioxidant status in serum among patients with polycystic ovarian syndrome
AbstractBackground and Aims: The most prevalent endocrine disease with unknown etiology among women in their fertility period is Polycystic Ovarian Syndrome (PCOS). The disease causes some changes in oxidative stress system, which in turn, is associated with such diseases as metabolicsyndrome, diabetes, cardiovascular diseases, and periodontitis. The present study investigated periodontal status and total antioxidant status in serum of women with PCOS.Materials and Methods: In this cross-sectional, analytic study eighty women, 40 with PCOS as cases and 40 infertile women without PCOS participated. Interview, oral examination and radiographs, and laboratory tests served as data collection tools. Body Mass Index (BMI), CommunityPeriodontal Index (CPI), Periodontal Disease Index (PDI), bone loss, and total anti-oxidant status (TAS) in serum of the participants were measured. Chi-squre test, Mann-Whithney test, and linear regression served for statistical analysis.Results: While in case group 21 patients had bone loss, in control group bone loss was found in 11 pateints (P=0.022). The distribution of maximum CPI score among cases was significantlydifferent from that among controls in that more frequent higher scores existed among cases (P=0.016). The mean PDI in case and control group was 6.23±3.3 and 4.48±2.6, respectively (P=0.015). In general linear model the level of serum TAS was significantly associated with CPI (P=0.039) and BMI (P=0.019).Conclusion: Women with PCOS seem to be more susceptible to periodontal disease compared to other women. This calls for comprehensive periodontal care and regular dental visits for patientwith PCOS.Keywords: Polycystic Ovarian Syndrome, Total Antioxidant Status, Periodontal Status, Community Periodontal Index, Periodontal disease Index.
Eman M. Sayed Ahmed, Mohamed E. Salem, Mohamed Samir Eid Sweed. Effect of Lifestyle Modifications on Polycystic Ovarian Syndrome Symptoms.Journal of American Science 2012; 8(8).
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, etal.onsensus on womans health aspects of polycysticovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS consensus workshopgroup. Fertil Steril. 2012 jan; 97 (1): 28-38.
Sam S, Dunaif A. Polycystic ovary syndrome:Syndromexx? Trends Endocrinol Metab. 2003 Oct;14(8):365-70.
Borges I Jr, Moreira EA, Filho DW, de Oliveira TB,da Silva MB, Fröde TS. Proinflammatory and oxidativestress markers in patients with periodontaldisease. Mediators Inflamm. 2007; 2007:45794.
Van der Velden U, Kuzmanova D, Chapple IL. Micronutritionalapproaches to periodontal therapyJ Clin Periodontol. 2011; 38(Suppl 11):142–58.
Halliwell B, Gutteridge JM. The antioxidants of humanextracellular fluids. Arch Biochem Biophys.1990 Jul; 280(1):1-8.
Murray RK, Granner DK, Mayes PA, Rodweii VW.Harper,s biochemistry. 23 ed.USA: Appleton &Lange;1993.
D’Aiuto F, Sabbah W, Netuveli G, Donos N, HingoraniAD, Deanfield J, et al. Assosiation of themetabolic syndrome with severe periodontitis in alarge U.S. population-based survey. J Clin EndocrinolMetab. 2008; 93:3989-94.
Kinane D, Bouchard P; Group E of European Workshopon Periodontology. Periodontal diseases andhealth: Consensus Report of the Sixth EuropeanWorkshop on Periodontology. J Clin Periodontol.2008 Sep; 35 (8Suppl):333-7.
Bullon P1, Morillo JM, Ramirez-Tortosa MC,Quiles JL, Newman HN, Battino M. Metabolicsyndrome and periodontitis: is oxidative stress acommon link? J Dent Res. 2009 Jun; 88(6):503-18.
Wolf HF, Hassell TM. Color Atlas of Dental HygienePeriodontology. New York: Thieme; 2006.
Dursun E1, Akalın FA, Güncü GN, Çınar N, AksoyDY, Tözüm TF, Kılınc K, Yıldız BO. Periodontaldisease in polycystic ovary syndrome. FertilSteril. 2011 Jan; 95(1):320-3.
Takane M, Sugano N, Ezawa T, Uchiyama T, Ito K.A marker of oxidative stress in saliva: associationwith periodontally-involved teeth of a hopelessprognosis. J Oral Sci. 2005 Mar; 47(1):53-7.
Newman MG, Takei HH, Carranza FA. Carenza’sClinical Periodontatology. 11th ed. Philadelphia:WB Saunders Co; 2011.104-6, 506-511.
Ozçaka O, Oztürk Ceyhan B, Akcali A, BiçakciN, Lappin DF, Budunelı N. Is there an InteractionBetween Polycystic Ovary Syndrome and GingivalInflammation? J Periodontol 2012 Apr 17.
González F1, Rote NS, Minium J, Kirwan JP. Increasedactivation of nuclear factor kappaB triggersinflammation and insulin resistance in polycysticovary syndrome. J Clin Endocrinol Metab.2006 Apr; 91(4):1508-12. Epub 2006 Feb 7.
Cerielo A1, Motz E, Cavarape A, Lizzio S, RussoA, Quatraro A, Giugliano D. Hyperglycemiacounterbalances the antihypertensive effect ofglutathione in diabetic patients: evidence linkinghypertension and glycemia through the oxidativestress in diabetes mellitus. J Diabetes Complications.1997 Jul-Aug; 11(4):250-5.
Kaneto H1, Katakami N, Kawamori D, MiyatsukaT, Sakamoto K, Matsuoka TA, Matsuhisa M, YamasakiY. Involvement of oxidative stress in thepathogenesis of diabetes. Antioxid Redox Signal.2007 Mar; 9 (3):355-66.
Liu J, Zhang D. The role of oxidative stress in thepathogenesis of polycystic ovary syndrome. SichuanDa Xue Xue Bao Yi Xue Ban. 2012 Mar;43(2):187-90.
Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome.J Clin Endocrinol Metab. 2008 Jan;93(1):162-8.
Akalin FA, Baltacioğlu E, Alver A, Karabulut E.Lipid peroxidation levels and total oxidant statusin serum, saliva and gingival crevicular fluid inpatients with chronic periodontitis. J Clin Periodontol.2007 Jul; 34(7):558-65.
Signorini AM, Fondelli C, Renzoni E, PuccettiC, Gragnoli G, Giorgi G. Antioxidant effect ofgliclazide,glibenclamide and metformin in patientswithtype 2 diabetes mellitus, Current TherapeuticResearch. 2002; 63:411–420.
A signature of author below certifies compliance with the following statements:
Copyright transfer; in signing this Agreement:
1. I hereby warrant that this article is an original work, has not been published before and is not being considered for publication elsewhere in its final form either in printed or electronic form;
2. I hereby warrant that you have obtained permission from the copyright holder to reproduce in the Article (in all media including print and electronic form) material not owned by you, and that you have acknowledged the source;
3. I hereby warrant that this article contains no violation of any existing copyright, moral rights or other third party right or any material of an obscene, indecent, defamatory or otherwise unlawful nature and that to the best of your knowledge this Article does not infringe the rights of others;
4. I hereby warrant that in the case of a multi-authored Article you have obtained, in writing, authorization to enter into this Agreement on their behalf and that all co-authors have read and agreed the terms of this agreement;
5. I warrant that any formula or dosage given is accurate and will not if properly followed injure any person;
6. I have made a significant scientific contribution to the study and I have read the complete manuscript and take responsibility for the content and completeness of the final surmised manuscript;
7. I will indemnify and keep indemnified the Editors, the Journal's Editor against all claims and expenses (including legal costs and expenses) arising from any breach of this warranty and the other warranties on your behalf in this Agreement.
Conflict of interest disclosure
All institutional or corporeal affixations of mine and all funding sources for the study are acknowledged. I certify that I have no commercial association that might represent a conflict of interest in connection with the submitted manuscript.